{"id":5809,"date":"2025-07-04T12:05:44","date_gmt":"2025-07-04T12:05:44","guid":{"rendered":"https:\/\/ecelis.it\/?p=5809"},"modified":"2025-07-04T12:08:43","modified_gmt":"2025-07-04T12:08:43","slug":"mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company","status":"publish","type":"post","link":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/","title":{"rendered":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  • Industry<\/strong>: Healthcare<\/li>
  • Tools and Technologies<\/strong>: Android<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Our client<\/b><\/h4>

    The client is a pharmaceutical startup in healthcare sector, aimed at developing Integrated AI driven Pharmacovigilance Services.<\/p>

    Challenge<\/h4>

    Development of a Mobile Application which allows stakeholders to report suspected ADRs directly to Pharma companies. It is used not only for information gathering but also for sharing of experiences, opinions and suggestions. For stakeholders, it is convenient to using forms to report ADR as companies can start working on ADR immediately and pharma company can maintain ‘watch list\u2019 of medicine for suspected reaction.<\/p>

    \u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Solution<\/h4>

    Development of a Mobile Application using android, stores data on backend data store for further processing and integrated with Pharmacovigilance software for further processing.<\/p>

    Result<\/h4>

    Development of a Mobile Application for Adverse Drug Reaction (ADR) reporting to pharma company, with Key benefits:<\/p>

    • For Stakeholders: It is convenient to use forms to report ADR.<\/li>
    • For Companies: they can start working on ADR immediately and can maintain \u2018watch list\u2019 of medicine for suspected reaction.<\/li><\/ul>

      \u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

      Industry: Healthcare Tools and Technologies: Android Our client The client is a pharmaceutical startup in healthcare sector, aimed at developing Integrated AI driven Pharmacovigilance Services. Challenge Development of a Mobile Application which allows stakeholders to report suspected ADRs directly to Pharma companies. It is used not only for information gathering but also for sharing of…<\/p>\n","protected":false},"author":4,"featured_media":5803,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[],"class_list":["post-5809","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\nMobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis\" \/>\n<meta property=\"og:description\" content=\"Industry: Healthcare Tools and Technologies: Android Our client The client is a pharmaceutical startup in healthcare sector, aimed at developing Integrated AI driven Pharmacovigilance Services. Challenge Development of a Mobile Application which allows stakeholders to report suspected ADRs directly to Pharma companies. It is used not only for information gathering but also for sharing of…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Ecelis\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-04T12:05:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-04T12:08:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Cristina Carenini\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Cristina Carenini\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\"},\"author\":{\"name\":\"Cristina Carenini\",\"@id\":\"https:\/\/ecelis.it\/en\/#\/schema\/person\/30fc89d7870d8ad5add68b7626c0d1c0\"},\"headline\":\"Mobile Application Development for Adverse Drug Reaction reporting to pharma company\",\"datePublished\":\"2025-07-04T12:05:44+00:00\",\"dateModified\":\"2025-07-04T12:08:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\"},\"wordCount\":174,\"publisher\":{\"@id\":\"https:\/\/ecelis.it\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg\",\"articleSection\":[\"news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\",\"url\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\",\"name\":\"Mobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis\",\"isPartOf\":{\"@id\":\"https:\/\/ecelis.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg\",\"datePublished\":\"2025-07-04T12:05:44+00:00\",\"dateModified\":\"2025-07-04T12:08:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage\",\"url\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg\",\"contentUrl\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ecelis.it\/en\/homepage\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mobile Application Development for Adverse Drug Reaction reporting to pharma company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ecelis.it\/en\/#website\",\"url\":\"https:\/\/ecelis.it\/en\/\",\"name\":\"Ecelis\",\"description\":\"Sviluppo delocalizzato in India sotto il vostro controllo\",\"publisher\":{\"@id\":\"https:\/\/ecelis.it\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ecelis.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ecelis.it\/en\/#organization\",\"name\":\"Ecelis\",\"url\":\"https:\/\/ecelis.it\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ecelis.it\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/01\/Ecelis-logo.webp\",\"contentUrl\":\"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/01\/Ecelis-logo.webp\",\"width\":1682,\"height\":423,\"caption\":\"Ecelis\"},\"image\":{\"@id\":\"https:\/\/ecelis.it\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ecelis.it\/en\/#\/schema\/person\/30fc89d7870d8ad5add68b7626c0d1c0\",\"name\":\"Cristina Carenini\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ecelis.it\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/24a57dc51fc9fa10d0079745a893b6722c527a5141a39c1d085c6ebbc895f419?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/24a57dc51fc9fa10d0079745a893b6722c527a5141a39c1d085c6ebbc895f419?s=96&d=mm&r=g\",\"caption\":\"Cristina Carenini\"},\"url\":\"https:\/\/ecelis.it\/en\/author\/cristina\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/","og_locale":"en_US","og_type":"article","og_title":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis","og_description":"Industry: Healthcare Tools and Technologies: Android Our client The client is a pharmaceutical startup in healthcare sector, aimed at developing Integrated AI driven Pharmacovigilance Services. Challenge Development of a Mobile Application which allows stakeholders to report suspected ADRs directly to Pharma companies. It is used not only for information gathering but also for sharing of…","og_url":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/","og_site_name":"Ecelis","article_published_time":"2025-07-04T12:05:44+00:00","article_modified_time":"2025-07-04T12:08:43+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg","type":"image\/jpeg"}],"author":"Cristina Carenini","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Cristina Carenini","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#article","isPartOf":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/"},"author":{"name":"Cristina Carenini","@id":"https:\/\/ecelis.it\/en\/#\/schema\/person\/30fc89d7870d8ad5add68b7626c0d1c0"},"headline":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company","datePublished":"2025-07-04T12:05:44+00:00","dateModified":"2025-07-04T12:08:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/"},"wordCount":174,"publisher":{"@id":"https:\/\/ecelis.it\/en\/#organization"},"image":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage"},"thumbnailUrl":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg","articleSection":["news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/","url":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/","name":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company - Ecelis","isPartOf":{"@id":"https:\/\/ecelis.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage"},"image":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage"},"thumbnailUrl":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg","datePublished":"2025-07-04T12:05:44+00:00","dateModified":"2025-07-04T12:08:43+00:00","breadcrumb":{"@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#primaryimage","url":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg","contentUrl":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/07\/CASE-HISTORY.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/ecelis.it\/en\/2025\/07\/mobile-application-development-for-adverse-drug-reaction-reporting-to-pharma-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ecelis.it\/en\/homepage\/"},{"@type":"ListItem","position":2,"name":"Mobile Application Development for Adverse Drug Reaction reporting to pharma company"}]},{"@type":"WebSite","@id":"https:\/\/ecelis.it\/en\/#website","url":"https:\/\/ecelis.it\/en\/","name":"Ecelis","description":"Sviluppo delocalizzato in India sotto il vostro controllo","publisher":{"@id":"https:\/\/ecelis.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ecelis.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ecelis.it\/en\/#organization","name":"Ecelis","url":"https:\/\/ecelis.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ecelis.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/01\/Ecelis-logo.webp","contentUrl":"https:\/\/ecelis.it\/wp-content\/uploads\/2025\/01\/Ecelis-logo.webp","width":1682,"height":423,"caption":"Ecelis"},"image":{"@id":"https:\/\/ecelis.it\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ecelis.it\/en\/#\/schema\/person\/30fc89d7870d8ad5add68b7626c0d1c0","name":"Cristina Carenini","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ecelis.it\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/24a57dc51fc9fa10d0079745a893b6722c527a5141a39c1d085c6ebbc895f419?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24a57dc51fc9fa10d0079745a893b6722c527a5141a39c1d085c6ebbc895f419?s=96&d=mm&r=g","caption":"Cristina Carenini"},"url":"https:\/\/ecelis.it\/en\/author\/cristina\/"}]}},"_links":{"self":[{"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/posts\/5809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/comments?post=5809"}],"version-history":[{"count":5,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/posts\/5809\/revisions"}],"predecessor-version":[{"id":5814,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/posts\/5809\/revisions\/5814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/media\/5803"}],"wp:attachment":[{"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/media?parent=5809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/categories?post=5809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ecelis.it\/en\/wp-json\/wp\/v2\/tags?post=5809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}